India Warns Pharma Companies Against Advertising Weight-Loss Drugs
India’s drug regulator has issued a fresh advisory warning pharmaceutical companies against promoting prescription weight-loss medicines to the general public. The notice specifically highlights GLP-1 therapies, widely used for obesity and diabetes treatment, and reiterates that such drugs cannot be advertised under existing Indian drug laws. The advisory, released by the Central Drugs Standard Control … Read more